Redmile Group as of June 30, 2022
Portfolio Holdings for Redmile Group
Redmile Group holds 71 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics (FATE) | 12.3 | $321M | 13M | 24.78 | |
| Amicus Therapeutics (FOLD) | 9.1 | $238M | 22M | 10.74 | |
| Seagen | 5.8 | $151M | 854k | 176.94 | |
| Argenx Se Sponsored Adr (ARGX) | 5.6 | $146M | 386k | 378.88 | |
| Krystal Biotech (KRYS) | 4.8 | $125M | 1.9M | 65.66 | |
| Livanova SHS (LIVN) | 3.9 | $101M | 1.6M | 62.47 | |
| Horizon Therapeutics Pub L SHS | 2.8 | $73M | 913k | 79.76 | |
| Beam Therapeutics (BEAM) | 2.7 | $72M | 1.8M | 38.71 | |
| The Beauty Health Company Com Cl A (SKIN) | 2.5 | $67M | 5.2M | 12.86 | |
| Replimune Group (REPL) | 2.4 | $64M | 3.6M | 17.48 | |
| Igm Biosciences (IGMS) | 2.3 | $60M | 3.3M | 18.03 | |
| Adc Therapeutics Sa SHS (ADCT) | 2.3 | $60M | 7.5M | 7.95 | |
| Celldex Therapeutics Com New (CLDX) | 2.1 | $56M | 2.1M | 26.96 | |
| Centene Corporation (CNC) | 2.1 | $55M | 651k | 84.61 | |
| Kymera Therapeutics (KYMR) | 2.0 | $51M | 2.6M | 19.69 | |
| Xenon Pharmaceuticals (XENE) | 1.9 | $50M | 1.6M | 30.42 | |
| Regenxbio Inc equity us cm (RGNX) | 1.9 | $50M | 2.0M | 24.70 | |
| Atara Biotherapeutics | 1.9 | $49M | 6.2M | 7.79 | |
| ImmunoGen | 1.6 | $41M | 9.1M | 4.50 | |
| Anthem (ELV) | 1.5 | $41M | 84k | 482.57 | |
| Science 37 Holdings | 1.5 | $40M | 20M | 2.01 | |
| Medavail Holdings Ord | 1.5 | $39M | 25M | 1.53 | |
| Nurix Therapeutics (NRIX) | 1.5 | $38M | 3.0M | 12.67 | |
| Repare Therapeutics Ord (RPTX) | 1.5 | $38M | 2.7M | 13.99 | |
| 1life Healthcare | 1.4 | $36M | 4.5M | 7.84 | |
| Verve Therapeutics (VERV) | 1.1 | $28M | 1.8M | 15.28 | |
| Absci Corp (ABSI) | 1.0 | $27M | 8.0M | 3.32 | |
| Stoke Therapeutics (STOK) | 1.0 | $26M | 2.0M | 13.21 | |
| Augmedix (AUGX) | 1.0 | $26M | 14M | 1.80 | |
| BioMarin Pharmaceutical (BMRN) | 0.9 | $25M | 300k | 82.87 | |
| Pliant Therapeutics (PLRX) | 0.9 | $25M | 3.1M | 8.01 | |
| Entrada Therapeutics (TRDA) | 0.9 | $24M | 2.0M | 12.18 | |
| Shattuck Labs (STTK) | 0.9 | $23M | 5.6M | 4.06 | |
| Oak Street Health | 0.9 | $23M | 1.4M | 16.44 | |
| Zymeworks | 0.8 | $20M | 3.8M | 5.30 | |
| Prothena Corp SHS (PRTA) | 0.8 | $20M | 736k | 27.15 | |
| Deciphera Pharmaceuticals | 0.7 | $19M | 1.4M | 13.15 | |
| Scholar Rock Hldg Corp (SRRK) | 0.7 | $19M | 3.4M | 5.49 | |
| Nevro (NVRO) | 0.7 | $18M | 406k | 43.83 | |
| Stevanato Group S P A Ord Shs (STVN) | 0.7 | $18M | 1.1M | 15.81 | |
| Gritstone Oncology Ord (GRTSQ) | 0.6 | $17M | 7.0M | 2.42 | |
| Akero Therapeutics (AKRO) | 0.6 | $15M | 1.6M | 9.45 | |
| Rapt Therapeutics | 0.6 | $15M | 818k | 18.25 | |
| Iveric Bio | 0.6 | $15M | 1.5M | 9.62 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.6 | $15M | 93k | 156.01 | |
| Annexon (ANNX) | 0.5 | $13M | 3.5M | 3.77 | |
| Nuvation Bio Com Cl A (NUVB) | 0.4 | $11M | 3.5M | 3.24 | |
| Tandem Diabetes Care Com New (TNDM) | 0.4 | $11M | 188k | 59.19 | |
| Somalogic Class A Com | 0.4 | $9.4M | 2.1M | 4.52 | |
| Invitae (NVTAQ) | 0.4 | $9.3M | 3.8M | 2.44 | |
| Bioventus Com Cl A (BVS) | 0.3 | $8.9M | 1.3M | 6.82 | |
| Oncology Institu (TOI) | 0.3 | $8.8M | 1.7M | 5.06 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.3 | $8.1M | 2.8M | 2.86 | |
| Allakos | 0.3 | $8.0M | 2.5M | 3.13 | |
| Hookipa Pharma Inc equity | 0.3 | $7.4M | 4.6M | 1.63 | |
| Adagio Therapeutics (IVVD) | 0.2 | $6.3M | 1.9M | 3.28 | |
| Alx Oncology Hldgs (ALXO) | 0.2 | $6.2M | 767k | 8.09 | |
| Privia Health Group (PRVA) | 0.2 | $6.0M | 206k | 29.12 | |
| Alpha Teknova (TKNO) | 0.2 | $4.8M | 568k | 8.40 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.2 | $4.1M | 1.6M | 2.52 | |
| Immatics SHS (IMTX) | 0.1 | $3.9M | 450k | 8.71 | |
| Neoleukin Therapeutics | 0.1 | $3.5M | 3.4M | 1.03 | |
| Allovir (ALVR) | 0.1 | $3.2M | 823k | 3.90 | |
| Tcr2 Therapeutics Inc cs | 0.1 | $3.2M | 1.1M | 2.90 | |
| Stereotaxis Com New (STXS) | 0.1 | $2.7M | 1.5M | 1.84 | |
| Xeris Pharmaceuticals (XERS) | 0.1 | $1.6M | 1.0M | 1.54 | |
| Atreca Cl A Com (BCEL) | 0.1 | $1.4M | 800k | 1.79 | |
| Sonendo (SONX) | 0.0 | $857k | 498k | 1.72 | |
| Cabaletta Bio (CABA) | 0.0 | $738k | 696k | 1.06 | |
| Cytosorbents Corp Com New (CTSO) | 0.0 | $583k | 266k | 2.19 | |
| Ayala Pharmaceuticals Incorporated | 0.0 | $372k | 341k | 1.09 |
